Annual Operating Expenses:
$581.86M+$39.27M(+7.24%)Summary
- As of today, NTLA annual total operating expenses is $581.86 million, with the most recent change of +$39.27 million (+7.24%) on December 31, 2024.
- During the last 3 years, NTLA annual operating expenses has risen by +$287.84 million (+97.90%).
- NTLA annual operating expenses is now at all-time high.
Performance
NTLA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Expenses:
$120.32M-$1.42M(-1.16%)Summary
- As of today, NTLA quarterly total operating expenses is $120.32 million, with the most recent change of -$1.42 million (-1.16%) on September 30, 2025.
- Over the past year, NTLA quarterly operating expenses has dropped by -$30.95 million (-20.46%).
- NTLA quarterly operating expenses is now -21.74% below its all-time high of $153.74 million, reached on March 31, 2022.
Performance
NTLA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
NTLA Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +7.2% | -20.5% |
| 3Y3 Years | +97.9% | +3.0% |
| 5Y5 Years | +447.0% | +328.2% |
NTLA Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +97.9% | -20.5% | +3.0% |
| 5Y | 5-Year | at high | +447.0% | -21.7% | +328.2% |
| All-Time | All-Time | at high | >+9999.0% | -21.7% | +4749.8% |
NTLA Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $120.32M(-1.2%) |
| Jun 2025 | - | $121.74M(-5.2%) |
| Mar 2025 | - | $128.44M(-12.5%) |
| Dec 2024 | $581.86M(+7.2%) | $146.75M(-3.0%) |
| Sep 2024 | - | $151.27M(+5.5%) |
| Jun 2024 | - | $143.40M(+2.1%) |
| Mar 2024 | - | $140.43M(+3.6%) |
| Dec 2023 | $542.59M(+7.9%) | $135.51M(-3.8%) |
| Sep 2023 | - | $140.81M(-2.1%) |
| Jun 2023 | - | $143.76M(+17.3%) |
| Mar 2023 | - | $122.51M(+0.7%) |
| Dec 2022 | $502.71M(+71.0%) | $121.63M(+4.1%) |
| Sep 2022 | - | $116.85M(+5.7%) |
| Jun 2022 | - | $110.49M(-28.1%) |
| Mar 2022 | - | $153.74M(+68.2%) |
| Dec 2021 | $294.01M(+115.3%) | $91.39M(+26.9%) |
| Sep 2021 | - | $71.99M(+4.3%) |
| Jun 2021 | - | $69.02M(+48.7%) |
| Mar 2021 | - | $46.42M(+9.5%) |
| Dec 2020 | $136.58M | $42.40M(+50.9%) |
| Sep 2020 | - | $28.10M(-14.9%) |
| Jun 2020 | - | $33.03M(-0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $33.05M(+11.0%) |
| Dec 2019 | $106.37M(+17.1%) | $29.77M(+17.5%) |
| Sep 2019 | - | $25.33M(-7.8%) |
| Jun 2019 | - | $27.46M(+15.3%) |
| Mar 2019 | - | $23.81M(+14.8%) |
| Dec 2018 | $90.87M(+30.6%) | $20.75M(-13.9%) |
| Sep 2018 | - | $24.10M(+2.1%) |
| Jun 2018 | - | $23.59M(+5.2%) |
| Mar 2018 | - | $22.43M(-9.2%) |
| Dec 2017 | $69.56M(+116.3%) | $24.71M(+55.7%) |
| Sep 2017 | - | $15.88M(-0.9%) |
| Jun 2017 | - | $16.02M(+23.7%) |
| Mar 2017 | - | $12.95M(+19.6%) |
| Dec 2016 | $32.16M(+139.8%) | $10.82M(+40.6%) |
| Sep 2016 | - | $7.70M(+10.8%) |
| Jun 2016 | - | $6.95M(+3.8%) |
| Mar 2016 | - | $6.69M(-6.8%) |
| Dec 2015 | $13.41M(+285.2%) | $7.18M(+44.0%) |
| Sep 2015 | - | $4.99M(+4.0%) |
| Jun 2015 | - | $4.80M(+93.4%) |
| Mar 2015 | - | $2.48M |
| Dec 2014 | $3.48M | - |
FAQ
- What is Intellia Therapeutics, Inc. annual total operating expenses?
- What is the all-time high annual operating expenses for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual operating expenses year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly total operating expenses?
- What is the all-time high quarterly operating expenses for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly operating expenses year-on-year change?
What is Intellia Therapeutics, Inc. annual total operating expenses?
The current annual operating expenses of NTLA is $581.86M
What is the all-time high annual operating expenses for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual total operating expenses is $581.86M
What is Intellia Therapeutics, Inc. annual operating expenses year-on-year change?
Over the past year, NTLA annual total operating expenses has changed by +$39.27M (+7.24%)
What is Intellia Therapeutics, Inc. quarterly total operating expenses?
The current quarterly operating expenses of NTLA is $120.32M
What is the all-time high quarterly operating expenses for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly total operating expenses is $153.74M
What is Intellia Therapeutics, Inc. quarterly operating expenses year-on-year change?
Over the past year, NTLA quarterly total operating expenses has changed by -$30.95M (-20.46%)